Germany · Delayed Price · Currency is EUR Legend Biotech Statistics
Total Valuation
Legend Biotech has a market cap or net worth of EUR 3.44 billion. The enterprise value is 2.85 billion.
| Market Cap | 3.44B |
| Enterprise Value | 2.85B |
Important Dates
The last earnings date was Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.92% |
| Shares Change (QoQ) | +4.70% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 53.99% |
| Float | 90.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 32.11 |
| PS Ratio | 3.09 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 3.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.23.
| Current Ratio | 3.04 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.28 |
| Interest Coverage | -2.24 |
Financial Efficiency
Return on equity (ROE) is -8.08% and return on invested capital (ROIC) is -9.91%.
| Return on Equity (ROE) | -8.08% |
| Return on Assets (ROA) | -1.92% |
| Return on Invested Capital (ROIC) | -9.91% |
| Return on Capital Employed (ROCE) | -3.92% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 347,768 |
| Profits Per Employee | -25,028 |
| Employee Count | 3,200 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 14.32 |
Taxes
In the past 12 months, Legend Biotech has paid 30.90 million in taxes.
| Income Tax | 30.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.60% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -39.60% |
| 50-Day Moving Average | 20.70 |
| 200-Day Moving Average | 20.12 |
| Relative Strength Index (RSI) | 45.25 |
| Average Volume (20 Days) | 22 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 6.49 |
Income Statement
In the last 12 months, Legend Biotech had revenue of EUR 1.11 billion and -80.09 million in losses. Loss per share was -0.44.
| Revenue | 1.11B |
| Gross Profit | 629.60M |
| Operating Income | -46.22M |
| Pretax Income | -49.19M |
| Net Income | -80.09M |
| EBITDA | -36.41M |
| EBIT | -46.22M |
| Loss Per Share | -0.44 |
Balance Sheet
The company has 844.31 million in cash and 243.51 million in debt, with a net cash position of 600.81 million.
| Cash & Cash Equivalents | 844.31M |
| Total Debt | 243.51M |
| Net Cash | 600.81M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.08B |
| Book Value Per Share | 5.55 |
| Working Capital | 721.07M |
Cash Flow
In the last 12 months, operating cash flow was -78.25 million and capital expenditures -28.36 million, giving a free cash flow of -106.61 million.
| Operating Cash Flow | -78.25M |
| Capital Expenditures | -28.36M |
| Depreciation & Amortization | 9.61M |
| Net Borrowing | -41.02M |
| Free Cash Flow | -106.61M |
| FCF Per Share | n/a |
Margins
Gross margin is 56.58%, with operating and profit margins of -4.15% and -7.20%.
| Gross Margin | 56.58% |
| Operating Margin | -4.15% |
| Pretax Margin | -4.42% |
| Profit Margin | -7.20% |
| EBITDA Margin | -3.27% |
| EBIT Margin | -4.15% |
| FCF Margin | n/a |
Dividends & Yields
Legend Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.92% |
| Shareholder Yield | -0.92% |
| Earnings Yield | -2.33% |
| FCF Yield | -3.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Legend Biotech has an Altman Z-Score of 5.57 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.57 |
| Piotroski F-Score | 2 |